The global number of COVID-19 cases and deaths has fallen for the sixth week in a row, marking a sharp downward trend in the pandemic. So much so, in fact, that many countries are planning a return to something resembling “normality” by June or July.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
Any drug or vaccine that is mass-produced must first go through a stage in the laboratory, and after the initial stages are completed, the test is performed on animals, and after receiving a positive result, further research is performed on a small number of humans.
Introduction to the method of making Corona virus vaccine by two big companies “Oxford” and “Moderna”
Updates around the development of Covid-19 vaccines seems to be an almost daily occurrence at the moment, as the best medical and scientific minds around the world look to provide an end to the current coronavirus pandemic. Vaccines from Moderna have produced high efficacy ratings in late trials, Janssen has launched a late stage clinical trial and now the University of Oxford / AstraZeneca jab has also returned encouraging results.